Fidelity Investments’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$175M Sell
5,383,666
-217,254
-4% -$7.12M 0.01% 926
2025
Q4
$178M Sell
5,600,920
-1,264,137
-18% -$38M 0.01% 917
2025
Q3
$161M Sell
6,865,057
-547,925
-7% -$9.39M 0.01% 943
2025
Q2
$84.1M Buy
7,412,982
+4,871,045
+192% +$46.2M ﹤0.01% 1191
2025
Q1
$16.9M Buy
2,541,937
+2,376,741
+1,439% +$22.2M ﹤0.01% 1735
2024
Q4
$1.82M Sell
165,196
-157,753
-49% -$1.94M ﹤0.01% 2473
2024
Q3
$3.97M Sell
322,949
-75,070
-19% -$1.06M ﹤0.01% 2192
2024
Q2
$5.38M Buy
398,019
+22,538
+6% +$304K ﹤0.01% 2059
2024
Q1
$5.07M Buy
375,481
+370,481
+7,410% +$2.24M ﹤0.01% 2078
2023
Q4
$26.3K Buy
5,000
+1,272
+34% +$5.44K ﹤0.01% 3809
2023
Q3
$14.7K Sell
3,728
-2,321,757
-100% -$15.3M ﹤0.01% 3963
2023
Q2
$24.7M Buy
2,325,485
+357,274
+18% +$3.8M ﹤0.01% 1557
2023
Q1
$16.4M Sell
1,968,211
-1,066,438
-35% -$9.62M ﹤0.01% 1696
2022
Q4
$28M Sell
3,034,649
-147,854
-5% -$1.54M ﹤0.01% 1482
2022
Q3
$40.9M Buy
3,182,503
+217,515
+7% +$3.47M ﹤0.01% 1327
2022
Q2
$39.2M Buy
2,964,988
+189,406
+7% +$2.88M ﹤0.01% 1370
2022
Q1
$58.4M Buy
2,775,582
+220,783
+9% +$4.42M ﹤0.01% 1330
2021
Q4
$61.3M Buy
2,554,799
+101,928
+4% +$2.43M ﹤0.01% 1341
2021
Q3
$62.4M Buy
2,452,871
+321,415
+15% +$8.96M ﹤0.01% 1320
2021
Q2
$71.7M Sell
2,131,456
-746,113
-26% -$26.4M 0.01% 1265
2021
Q1
$112M Sell
2,877,569
-723,406
-20% -$41.2M 0.01% 1019
2020
Q4
$223M Buy
3,600,975
+1,659,095
+85% +$76.1M 0.02% 696
2020
Q3
$65M Buy
1,941,880
+1,170,014
+152% +$33.4M 0.01% 1093
2020
Q2
$18.4M Buy
771,866
+305,519
+66% +$7.25M ﹤0.01% 1584
2020
Q1
$10.7M Sell
466,347
-88,050
-16% -$2.18M ﹤0.01% 1672
2019
Q4
$15.7M Buy
554,397
+111,384
+25% +$2.8M ﹤0.01% 1687
2019
Q3
$9.52M Sell
443,013
-206,987
-32% -$5.77M ﹤0.01% 1847
2019
Q2
$19M Buy
+650,000
New +$17.5M ﹤0.01% 1639

Other funds holding STOK